Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 75 of 93 entries
View as:

Cohort Study on People Who Inject Drugs in Senegal

Phase: N/A Priority: Normal
NCT ID: NCT03459768 Org: User:
Start: 08/24/16 End: 06/30/21 Due: 06/30/22

Chronic Hepatitis C Treatment by Pegylated Interferon and Ribavirin in Naive Egyptian Patients (ANRS 1211)

Phase: N/A Priority: Normal
NCT ID: NCT00158496 Org: User:
Start: 08/31/02 End: 01/31/05 Due: 01/31/06

Evaluation of 2 Interferon γ Assays in the Diagnosis of Latent Tuberculosis in HIV-infected Patients.ANRS EP 40 QUANTI SPOT

Phase: N/A Priority: Normal
NCT ID: NCT00647205 Org: User:
Start: 01/31/08 End: 11/30/10 Due: 11/30/11

Intermittent Therapy in HIV-1 Infected Patients With Successful Viral Suppression Under Highly Active Antiretroviral Therapy (HAART)

Phase: N/A Priority: Normal
NCT ID: NCT00122551 Org: User:
Start: 12/31/01 End: 04/30/05 Due: 04/30/06

Accelerated Aging, HIV Infection, Antiretroviral Therapies

Phase: N/A Priority: Normal
NCT ID: NCT01038999 Org: User:
Start: 04/30/09 End: 03/31/12 Due: 03/31/13

Triple Therapy With Peg-Interferon Alfa-2b/Ribavirin Plus Amantadine Compared to Standard Peg-Interferon Alfa-2b/Ribavirin for Previous Hepatitis C Virus (HCV) Non Responders

Phase: N/A Priority: Normal
NCT ID: NCT00122629 Org: User:
Start: 10/31/00 End: 05/31/03 Due: 05/31/04

Tenofovir/Emtricitabine for PMTCT in Africa and Asia (ANRS 12109 TEmAA)

Phase: N/A Priority: Normal
NCT ID: NCT00334256 Org: User:
Start: 10/31/06 End: 12/31/09 Due: 12/31/10

Pilot Study on Once Daily FTC, ddI, Efavirenz Combination in Antiretroviral Naive HIV Infected Adults

Phase: N/A Priority: Normal
NCT ID: NCT00196599 Org: User:
Start: 02/28/99 End: 09/30/04 Due: 09/30/05

Efficacy and Safety of Tenofovir DF/Atazanavir Enhanced With Low Dose of Ritonavir in HIV-Infected Patients

Phase: N/A Priority: Normal
NCT ID: NCT00122577 Org: User:
Start: 03/31/02 End: 07/31/04 Due: 07/31/05

Interferon Gamma With Peg-Interferon Alpha 2a and Ribavirin in Non Responders Patients With Chronic Hepatitis C

Phase: N/A Priority: Normal
NCT ID: NCT00148863 Org: User:
Start: 06/30/04 End: 08/31/07 Due: 08/31/08

Efficacy of Alendronate Versus Placebo in the Treatment of HIV-associated Osteoporosis (ANRS120)

Phase: N/A Priority: Normal
NCT ID: NCT00120757 Org: User:
Start: 10/31/04 End: 11/30/08 Due: 11/30/09

Rosuvastatin Versus Pravastatin in HIV Patients Treated With Boosted Protease Inhibitors (PI) (ANRS126)

Phase: N/A Priority: Normal
NCT ID: NCT00117494 Org: User:
Start: 10/31/05 End: 06/30/07 Due: 06/30/08

HIV Immune and Virological Responses Following the Administration of IL-2 Either Alone or Combined to ALVAC-HIV 1433 and HIV Lipopeptides in Patients Treated Early With HAART During Primary Infection

Phase: N/A Priority: Normal
NCT ID: NCT00196651 Org: User:
Start: 08/31/00 End: 02/29/04 Due: 02/28/05

Efficacy of Prazosin Versus Placebo Associated With Peg-Interferon Alpha 2b and Ribavirin in Chronic Hepatitis C With Genotype 1 or 4 and Severe Fibrosis

Phase: N/A Priority: Normal
NCT ID: NCT00148837 Org: User:
Start: 09/30/04 End: - Due: -

Pioglitazone vs. Placebo in Association With Pegylated Interferon and Ribavirin in HCV Patients With Insulin Resistance

Phase: N/A Priority: Normal
NCT ID: NCT00927290 Org: User:
Start: 12/03/09 End: 07/06/12 Due: 07/06/13

Study of Human Papillomavirus Related Genital Pathology Among HIV Positive Women

Phase: N/A Priority: Normal
NCT ID: NCT01311752 Org: User:
Start: 11/30/07 End: 12/31/12 Due: 12/31/13

Residual Replication of HIV-1 in the Gut Associated Lymphoid Tissue (GALT) of Patients on Highly Active Antiretroviral Therapy (HAART): the ANRS EP 44 Study

Phase: N/A Priority: Normal
NCT ID: NCT01038401 Org: User:
Start: 09/30/08 End: 05/31/10 Due: 05/31/11

Evaluation of Clinical Efficacy and Immunologic Response After IL-2 Therapy in HCV-related Vasculitis Patients

Phase: N/A Priority: Normal
NCT ID: NCT00574652 Org: User:
Start: 03/31/08 End: 09/30/10 Due: 09/30/11

Structured Treatment Interruptions With or Without Pegylated Interferon Alpha for HIV-Infected Patients After Prolonged Viral Suppression

Phase: N/A Priority: Normal
NCT ID: NCT00125814 Org: User:
Start: 12/31/01 End: 01/31/05 Due: 01/31/06

Residual Risk Assessment Of HIV Transmission

Phase: N/A Priority: Normal
NCT ID: NCT01413152 Org: User:
Start: 07/31/11 End: 03/31/12 Due: 03/31/13

Efficacy of Pegylated Interferon on Liver Fibrosis in Co-infected Patient With HIV and Hepatitis C

Phase: N/A Priority: Normal
NCT ID: NCT00122616 Org: User:
Start: 11/30/03 End: 03/31/09 Due: 03/31/10

Measure of Pharmacokinetic Parameters and Adherence With MEMS in Naive HIV Infected Patients Treated With Reyataz Once Daily Combined With Norvir and Truvada

Phase: N/A Priority: Normal
NCT ID: NCT00528060 Org: User:
Start: 01/31/08 End: 11/30/08 Due: 11/30/09

Once-daily Highly Active Antiretroviral Treatment Regimen Administration in HIV-1 Infected Children in Burkina Faso (ANRS 12103 BURKINAME)

Phase: N/A Priority: Normal
NCT ID: NCT00122538 Org: User:
Start: 02/28/06 End: 05/31/09 Due: 05/31/10

Intensification With Enfuvirtide in Naive HIV-infected Patients (ANRS130)

Phase: N/A Priority: Normal
NCT ID: NCT00302822 Org: User:
Start: 04/30/06 End: 12/31/09 Due: 12/31/10

Once Daily Antiretroviral Therapy in HIV Infected Adults Treated With HAART

Phase: N/A Priority: Normal
NCT ID: NCT00196612 Org: User:
Start: 04/30/01 End: 09/30/04 Due: 09/30/05